miércoles, 22 de julio de 2020

NIAID and Partners to Develop Antibody-Based Products for HIV Prevention and Treatment | HIV.gov

NIAID and Partners to Develop Antibody-Based Products for HIV Prevention and Treatment | HIV.gov

Model of the VRC01 antibody.

NIAID and Partners to Develop Antibody-Based Products for HIV Prevention and Treatment
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, and IAVI, a nonprofit scientific research organization, recently announced a collaboration to develop combinations of HIV broadly neutralizing antibodies (bNAbs) that could be produced on a large scale at low cost to prevent and possibly treat HIV.
LEARN MORE

No hay comentarios:

Publicar un comentario